| Name | prefoldin subunit 1 |
| Description | This gene encodes a member of the prefoldin beta subunit family. The encoded protein is one of six subunits of prefoldin, a molecular chaperone complex that binds and stabilizes newly synthesized polypeptides, thereby allowing them to fold correctly. The complex, consisting of two alpha and four beta subunits, forms a double beta barrel assembly with six protruding coiled-coils. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough the query asks about PFDN1, none of the provided abstracts describe any function of PFDN1. Instead, the collective work focuses on the suppressor of cytokine signaling (SOCS) proteins and their crucial role as intracellular negative regulators of diverse cytokine‐ and Toll‐like receptor–mediated signal transduction pathways. These studies reveal that SOCS molecules are rapidly induced in response to inflammatory cues, where they serve as “molecular brakes” to attenuate signaling cascades and thereby prevent pathologic overactivation of immune responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several reports, SOCS proteins are shown to modulate key cellular signaling pathways by binding to receptor‐associated kinases and substrates—often facilitating their ubiquitination and subsequent degradation. For example, SOCS1 and SOCS3 can target insulin receptor substrates or adaptor proteins in Toll‐like receptor signaling, thereby impairing cytokine receptor transduction essential for insulin action and innate immunity. This mechanism is central to limiting insulin resistance, curbing excessive inflammatory cytokine production, and protecting the host from endotoxin shock and other inflammatory insults."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther studies in the collection emphasize the role of SOCS proteins in fine‐tuning adaptive immunity. For instance, SOCS1–miR155 interactions in regulatory T cells and macrophages help balance STAT activation and thus influence T cell lineage differentiation as well as macrophage polarization. These regulatory circuits are critical for maintaining immune homeostasis and preventing the development of autoimmunity or chronic inflammatory diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA further set of reports illustrates how SOCS proteins regulate broader aspects of immune responses—including tumor immunity, autoimmunity, antiviral defense, and tissue inflammation (such as liver fibrosis and colorectal carcinogenesis)—through modulation of the JAK–STAT and NF‐κB pathways. By curtailing the duration and magnitude of cytokine receptor signaling, SOCS proteins avert uncontrolled inflammatory mediator production and protect tissues from damage. In sum, these studies collectively underscore that while no information on PFDN1 is provided, the SOCS family emerges as key modulators in diverse physiological and pathological processes by actively down‐regulating cytokine and Toll‐like receptor signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Liangyou Rui, Minsheng Yuan, Daniel Frantz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C200444200"}], "href": "https://doi.org/10.1074/jbc.C200444200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12228220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12228220"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ichiko Kinjyo, Toshikatsu Hanada, Kyoko Inagaki-Ohara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SOCS1/JAB is a negative regulator of LPS-induced macrophage activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1074-7613(02)00446-6"}], "href": "https://doi.org/10.1016/s1074-7613(02"}, {"type": "t", "text": "00446-6) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12433365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12433365"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Reiko Nakagawa, Tetsuji Naka, Hiroko Tsutsui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SOCS-1 participates in negative regulation of LPS responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1074-7613(02)00449-1"}], "href": "https://doi.org/10.1016/s1074-7613(02"}, {"type": "t", "text": "00449-1) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12433373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12433373"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kohjiro Ueki, Tatsuya Kondo, C Ronald Kahn "}, {"type": "b", "children": [{"type": "t", "text": "Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.24.12.5434-5446.2004"}], "href": "https://doi.org/10.1128/MCB.24.12.5434-5446.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15169905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15169905"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kohjiro Ueki, Tatsuya Kondo, Yu-Hua Tseng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0402511101"}], "href": "https://doi.org/10.1073/pnas.0402511101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15240880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15240880"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ashley Mansell, Rosealee Smith, Sarah L Doyle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni1299"}], "href": "https://doi.org/10.1038/ni1299"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16415872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16415872"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Pin Wang, Jin Hou, Li Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1000491"}], "href": "https://doi.org/10.4049/jimmunol.1000491"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20937844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20937844"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Andrea Baetz, Markus Frey, Klaus Heeg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M410992200"}], "href": "https://doi.org/10.1074/jbc.M410992200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15491991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15491991"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lei Shen, Kevin Evel-Kabler, Randy Strube, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Biotechnol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nbt1035"}], "href": "https://doi.org/10.1038/nbt1035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15558048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15558048"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Li-Fan Lu, To-Ha Thai, Dinis Pedro Calado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2008.11.010"}], "href": "https://doi.org/10.1016/j.immuni.2008.11.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19144316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19144316"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ana L Cardoso, Joana R Guedes, Luís Pereira de Almeida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2567.2011.03514.x"}], "href": "https://doi.org/10.1111/j.1365-2567.2011.03514.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22043967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22043967"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Rui Yao, Yu-Lan Ma, Wei Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0046082"}], "href": "https://doi.org/10.1371/journal.pone.0046082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23091595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23091595"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Katriina J Peltola, Kirsi Paukku, Teija L T Aho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2003-09-3126"}], "href": "https://doi.org/10.1182/blood-2003-09-3126"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14764533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14764533"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Samuel Wormald, Jian-Guo Zhang, Danielle L Krebs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M509595200"}], "href": "https://doi.org/10.1074/jbc.M509595200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16473883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16473883"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Carlos H Serezani, Casey Lewis, Sonia Jancar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI43302"}], "href": "https://doi.org/10.1172/JCI43302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21206089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21206089"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jun Zhang, Hongying Zhao, Jinping Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2012.06.047"}], "href": "https://doi.org/10.1016/j.febslet.2012.06.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22771905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22771905"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Emilie Bourdonnay, Zbigniew Zasłona, Loka Raghu Kumar Penke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20141675"}], "href": "https://doi.org/10.1084/jem.20141675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25847945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25847945"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kangfeng Jiang, Jing Yang, Shuai Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peripheral Circulating Exosome-Mediated Delivery of miR-155 as a Novel Mechanism for Acute Lung Inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymthe.2019.07.003"}], "href": "https://doi.org/10.1016/j.ymthe.2019.07.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31405809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31405809"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Donald Metcalf, Sandra Mifsud, Ladina Di Rago, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.022628499"}], "href": "https://doi.org/10.1073/pnas.022628499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11782537"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11782537"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Toshikichi Hayashi, Toshio Kaneda, Yoshiaki Toyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M203836200"}], "href": "https://doi.org/10.1074/jbc.M203836200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12023971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12023971"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Joanne L Eyles, Donald Metcalf, Michael J Grusby, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M208586200"}], "href": "https://doi.org/10.1074/jbc.M208586200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12221108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12221108"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ann L Cornish, Mark M Chong, Gayle M Davey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M303021200"}], "href": "https://doi.org/10.1074/jbc.M303021200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12665516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12665516"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sébastien Gingras, Evan Parganas, Antoine de Pauw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M411043200"}], "href": "https://doi.org/10.1074/jbc.M411043200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15491990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15491990"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Toshikatsu Hanada, Kentaro Tanaka, Yumiko Matsumura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.174.7.4325"}], "href": "https://doi.org/10.4049/jimmunol.174.7.4325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15778397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15778397"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Akihiro Kimura, Tetsuji Naka, Tatsushi Muta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0508517102"}], "href": "https://doi.org/10.1073/pnas.0508517102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16287972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16287972"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kevin Evel-Kabler, Xiao-Tong Song, Melissa Aldrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI26169"}], "href": "https://doi.org/10.1172/JCI26169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16357940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16357940"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yun He, Wei Zhang, Rong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512338200"}], "href": "https://doi.org/10.1074/jbc.M512338200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16407264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16407264"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Stefan Zimmermann, Peter J Murray, Klaus Heeg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.176.3.1840"}], "href": "https://doi.org/10.4049/jimmunol.176.3.1840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16424215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16424215"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Hongwei Qin, Cynthia A Wilson, Sun Jung Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.05-5493fje"}], "href": "https://doi.org/10.1096/fj.05-5493fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16571771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16571771"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Toshikatsu Hanada, Takashi Kobayashi, Takatoshi Chinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20060436"}], "href": "https://doi.org/10.1084/jem.20060436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16717119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16717119"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hongwei Qin, Sandrine A Niyongere, Sun Jung Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.181.5.3167"}], "href": "https://doi.org/10.4049/jimmunol.181.5.3167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18713987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18713987"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Guadalupe Ortiz-Muñoz, Jose Luis Martin-Ventura, Purificacion Hernandez-Vargas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.108.173781"}], "href": "https://doi.org/10.1161/ATVBAHA.108.173781"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19164812"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19164812"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Jeffrey J Babon, Jennifer K Sabo, Jian-Guo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2009.01.024"}], "href": "https://doi.org/10.1016/j.jmb.2009.01.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19385048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19385048"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Yun Sang Lee, Ahjoku Amadi-Obi, Cheng-Rong Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2567.2010.03379.x"}], "href": "https://doi.org/10.1111/j.1365-2567.2010.03379.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21294722"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21294722"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Takatoshi Chinen, Kyoko Komai, Go Muto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms1181"}], "href": "https://doi.org/10.1038/ncomms1181"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21304519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21304519"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ye-Ji Lee, Ji-Young Han, Jiyeon Byun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.0611289"}], "href": "https://doi.org/10.1189/jlb.0611289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22427680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22427680"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Haitao Wei, Song Wang, Qinghuang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Pathog (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.ppat.1003845"}], "href": "https://doi.org/10.1371/journal.ppat.1003845"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24391501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24391501"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Mirza Saqib Baig, Sofia V Zaichick, Mao Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20140654"}], "href": "https://doi.org/10.1084/jem.20140654"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26324446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26324446"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Jinshan Ye, Ruiwei Guo, Yankun Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mediators Inflamm (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2016/8060182"}], "href": "https://doi.org/10.1155/2016/8060182"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27843203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27843203"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Yan-Bing Liang, Hao Tang, Zhi-Bin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.7384"}], "href": "https://doi.org/10.3892/mmr.2017.7384"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28901399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28901399"}]}]}]}
|
| Synonyms | PFD1, PDF |
| Proteins | PFD1_HUMAN |
| NCBI Gene ID | 5201 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PFDN1 has 6,448 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 114 datasets.
Click the + buttons to view associations for PFDN1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PFDN1 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PFDN1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PFDN1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PFDN1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PFDN1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PFDN1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PFDN1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PFDN1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PFDN1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PFDN1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PFDN1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PFDN1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PFDN1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing PFDN1 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PFDN1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PFDN1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PFDN1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PFDN1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PFDN1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PFDN1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PFDN1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing PFDN1 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PFDN1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PFDN1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PFDN1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PFDN1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PFDN1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PFDN1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PFDN1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PFDN1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PFDN1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PFDN1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PFDN1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PFDN1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PFDN1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PFDN1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PFDN1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PFDN1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PFDN1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PFDN1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PFDN1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PFDN1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PFDN1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PFDN1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PFDN1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PFDN1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PFDN1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PFDN1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PFDN1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PFDN1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PFDN1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PFDN1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PFDN1 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PFDN1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PFDN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PFDN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PFDN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PFDN1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PFDN1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PFDN1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PFDN1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PFDN1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PFDN1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PFDN1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PFDN1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PFDN1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PFDN1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PFDN1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for PFDN1 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PFDN1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PFDN1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PFDN1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PFDN1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PFDN1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PFDN1 protein from the Wikipathways PFOCR 2024 dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PFDN1 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving PFDN1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PFDN1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PFDN1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PFDN1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PFDN1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PFDN1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PFDN1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PFDN1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PFDN1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PFDN1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PFDN1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PFDN1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PFDN1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PFDN1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PFDN1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PFDN1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PFDN1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PFDN1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PFDN1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PFDN1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PFDN1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PFDN1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PFDN1 protein from the WikiPathways Pathways 2024 dataset. | |